<?xml version="1.0" encoding="UTF-8"?>
<p id="p0160">
 <italic>mRNA-1273</italic> from Moderna is a lipid encapsulated mRNA vaccine and is undergoing safety and immune response phase I trial in Seattle. The company has filed for an IND to go for parallel phase II trials (
 <xref rid="bib61" ref-type="bibr">61</xref>, 
 <xref rid="bib75" ref-type="bibr">75</xref>).
</p>
